Therapeutic-area Dossier
Psychiatry
Therapeutic-area Dossier for Psychiatry (mental health medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC outcomes — compiled…
- Brand: ABILIFY
- Brand: ABILIFY
- Brand: ALEPAM
- Brand: ALLEGRON
- Brand: ALODORM
- Brand: ALPRAX
- Sponsor: Arrotex Pharmaceuticals
- Sponsor: Alphapharm
- Sponsor: GM Pharma
- Sponsor: Ipca Pharma
What is
Psychiatry Psychiatry covers 82 registered brands in the therapeutic area. The field encompasses medications and treatments used in the management of psychiatric and mental health conditions.
Brands registered in Psychiatry The top brands registered in this area are:
— AMISULPRIDE — APX-DIAZEPAM — CAMPRAL — CLOPIXOL — HALDOL — LEXOTAN — NEULACTIL — NICABATE — NICOTINELL — SOLIAN — SUBUTEX — VARENAPIX
Sponsor landscape
The psychiatry area has 35 sponsors active across the registered brands . Key sponsors include Arrotex Pharmaceuticals, Alphapharm, GM Pharma, H W Woods, Maple Healthcare, Sun Pharma, BLS Wholesalers, and Noumed Pharmaceuticals .
PBS and regulatory activity
Thirteen brands in psychiatry have PBS-listed items, with the latest PBS schedule date for this area being 1 May 2026 . The most recent PBAC outcome in this area was recorded on 1 November 2018, with 5 brands holding PBAC outcomes on record . The most recent AusPAR was published on 7 December 2010, with 1 brand holding an AusPAR on record .